Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
Life Sciences
|
September 18, 1998
Reduction of stress-induced analgesia following ethanol exposure in mice
R L Bell, R D Soignier, R D Olson, et al.
Life Sciences
|
July 30, 1979
CNS effects of peripherally administered brain peptides
A J Kastin, R D Olson, A V Schally, et al.
Peptides
|
January 1, 1981
Effects of MIF-I and sex differences on tonic immobility duration in the lizard, Anolis carolinensis
F M Cashner, R D Olson, D G Erickson, et al.
Annals of the New York Academy of Sciences
|
October 31, 1994
Novel concepts from novel peptides
A J Kastin, W A Banks, R D Olson, et al.
Psychoneuroendocrinology
|
January 1, 1980
Behavioral effects after systemic injection of opiate peptides
R D Olson, A J Kastin, G A Olson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1978
Doxorubicin: inotropic effects and inhibitory action on ouabain
C J van Boxtel, R D Olson, R C Boerth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 26, 1999
Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723
B Musser, R V Mudumbi, J Liu, et al.
Pharmacology, Biochemistry, and Behavior
|
July 1, 1993
Picrotoxin-induced seizures modified by morphine and opiate antagonists
J Thomas, W L Nores, V Kenigs, et al.
Journal of Molecular and Cellular Cardiology
|
November 5, 1997
Contractile failure in chronic doxorubicin-induced cardiomyopathy
R J Boucek, D A Dodd, J B Atkinson, et al.
British Journal of Pharmacology
|
August 26, 2000
Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat
B E Burke, H Gambliel, R D Olson, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
Life Sciences
|
September 18, 1998
Reduction of stress-induced analgesia following ethanol exposure in mice
R L Bell, R D Soignier, R D Olson, et al.
Life Sciences
|
July 30, 1979
CNS effects of peripherally administered brain peptides
A J Kastin, R D Olson, A V Schally, et al.
Peptides
|
January 1, 1981
Effects of MIF-I and sex differences on tonic immobility duration in the lizard, Anolis carolinensis
F M Cashner, R D Olson, D G Erickson, et al.
Annals of the New York Academy of Sciences
|
October 31, 1994
Novel concepts from novel peptides
A J Kastin, W A Banks, R D Olson, et al.
Psychoneuroendocrinology
|
January 1, 1980
Behavioral effects after systemic injection of opiate peptides
R D Olson, A J Kastin, G A Olson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1978
Doxorubicin: inotropic effects and inhibitory action on ouabain
C J van Boxtel, R D Olson, R C Boerth, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 26, 1999
Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723
B Musser, R V Mudumbi, J Liu, et al.
Pharmacology, Biochemistry, and Behavior
|
July 1, 1993
Picrotoxin-induced seizures modified by morphine and opiate antagonists
J Thomas, W L Nores, V Kenigs, et al.
Journal of Molecular and Cellular Cardiology
|
November 5, 1997
Contractile failure in chronic doxorubicin-induced cardiomyopathy
R J Boucek, D A Dodd, J B Atkinson, et al.
British Journal of Pharmacology
|
August 26, 2000
Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat
B E Burke, H Gambliel, R D Olson, et al.
Page
of 14